Rapid Emergence and Spread of Severe Acute Respiratory Syndrome Coronavirus 2 Gamma (P.1) Variant in Haiti

After an initial wave of coronavirus disease 2019 (COVID-19) in Haiti in summer 2020 (primarily lineage B.1), seropositivity for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) was ~40%. Variant P.1 (gamma) was introduced in February 2021, with an initially l...

Descripción completa

Detalles Bibliográficos
Autores principales: Tagliamonte, Massimiliano S, Mavian, Carla, Zainabadi, Kayvan, Cash, Melanie N, Lednicky, John A, Magalis, Brittany Rife, Riva, Alberto, Deschamps, Marie Marcelle, Liautaud, Bernard, Rouzier, Vanessa, Fitzgerald, Daniel W, Pape, Jean William, Morris, J Glenn, Salemi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524302/
https://www.ncbi.nlm.nih.gov/pubmed/34471930
http://dx.doi.org/10.1093/cid/ciab736
Descripción
Sumario:After an initial wave of coronavirus disease 2019 (COVID-19) in Haiti in summer 2020 (primarily lineage B.1), seropositivity for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) was ~40%. Variant P.1 (gamma) was introduced in February 2021, with an initially limited introduction followed by exponential local dissemination within this unvaccinated population with prior exposure to earlier SARS-CoV-2 lineages.

Ejemplares similares